202 related articles for article (PubMed ID: 28893287)
1. Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.
Bernard NF
AIDS Res Ther; 2017 Sep; 14(1):38. PubMed ID: 28893287
[TBL] [Abstract][Full Text] [Related]
2. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
[TBL] [Abstract][Full Text] [Related]
3. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
[TBL] [Abstract][Full Text] [Related]
4. The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.
Lisovsky I; Isitman G; Tremblay-McLean A; Song R; DaFonseca S; Lebouchẻ B; Routy JP; Bruneau J; Bernard NF
Clin Exp Immunol; 2016 Dec; 186(3):336-346. PubMed ID: 27506421
[TBL] [Abstract][Full Text] [Related]
5. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
6. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
[TBL] [Abstract][Full Text] [Related]
7. HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.
Kiani Z; Bruneau J; Geraghty DE; Bernard NF
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270222
[TBL] [Abstract][Full Text] [Related]
8. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
[TBL] [Abstract][Full Text] [Related]
9. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
[TBL] [Abstract][Full Text] [Related]
10. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
[TBL] [Abstract][Full Text] [Related]
11. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
[TBL] [Abstract][Full Text] [Related]
12. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.
Boudreau JE; Mulrooney TJ; Le Luduec JB; Barker E; Hsu KC
J Immunol; 2016 Apr; 196(8):3398-410. PubMed ID: 26962229
[TBL] [Abstract][Full Text] [Related]
13. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
[TBL] [Abstract][Full Text] [Related]
14. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.
Merino AM; Sabbaj S; Easlick J; Goepfert P; Kaslow RA; Tang J
Clin Exp Immunol; 2013 Dec; 174(3):414-23. PubMed ID: 23952339
[TBL] [Abstract][Full Text] [Related]
15. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.
Alter G; Rihn S; Walter K; Nolting A; Martin M; Rosenberg ES; Miller JS; Carrington M; Altfeld M
J Virol; 2009 Jul; 83(13):6798-805. PubMed ID: 19386717
[TBL] [Abstract][Full Text] [Related]
16. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts.
Ward JP; Bonaparte MI; Barker E
AIDS; 2004 Sep; 18(13):1769-79. PubMed ID: 15316337
[TBL] [Abstract][Full Text] [Related]
17. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
18. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
[TBL] [Abstract][Full Text] [Related]
19. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
20. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.
Jackson E; Zhang CX; Kiani Z; Lisovsky I; Tallon B; Del Corpo A; Gilbert L; Bruneau J; Thomas R; Côté P; Trottier B; LeBlanc R; Rouleau D; Tremblay C; Tsoukas CM; Routy JP; Ni X; Mabanga T; Bernard NF;
PLoS One; 2017; 12(9):e0185160. PubMed ID: 28938026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
